|
MAP1LC3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.41800040995588E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88840000303614E-08 |
| Normal-vs-Stage2 |
2.376300E-04 |
| Normal-vs-Stage3 |
1.322040E-03 |
| Normal-vs-Stage4 |
1.327200E-01 |
| Stage1-vs-Stage2 |
7.592600E-01 |
| Stage1-vs-Stage3 |
4.534000E-01 |
| Stage1-vs-Stage4 |
5.012000E-01 |
| Stage2-vs-Stage3 |
6.710600E-01 |
| Stage2-vs-Stage4 |
3.782000E-01 |
| Stage3-vs-Stage4 |
3.593200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.06869982150226E-10 |
| Normal-vs-AfricanAmerican |
2.44309999999359E-05 |
| Normal-vs-Asian |
4.749600E-01 |
| Caucasian-vs-AfricanAmerican |
3.927400E-01 |
| Caucasian-vs-Asian |
4.137400E-01 |
| AfricanAmerican-vs-Asian |
5.883800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04290021063491E-10 |
| Normal-vs-Female |
3.99370000000454E-05 |
| Male-vs-Female |
8.482400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.140400E-03 |
| Normal-vs-Extreme_Weight |
3.4403000004346E-08 |
| Normal-vs-Obese |
1.79149999945949E-07 |
| Normal-vs-Extreme_Obese |
1.293220E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.046500E-02 |
| Normal_Weight-vs-Obese |
2.544500E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.705600E-01 |
| Extreme_Weight-vs-Obese |
8.433400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.348000E-01 |
| Obese-vs-Extreme_Obese |
3.898600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.422200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.10059985966882E-10 |
| Normal-vs-Age(61-80Yrs) |
3.82670000020902E-07 |
| Normal-vs-Age(81-100Yrs) |
1.884840E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.977800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.494370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.054000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.016400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.490600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.431400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.18147722108597E-12 |
| Normal-VS-Type2 PRCC |
1.929950E-02 |
| Normal-VS-KIRP CIMP |
2.978300E-03 |
| Normal-VS-Unclassified PRCC |
4.32460000000523E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.46520000002359E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.163000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.955000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.556800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.418100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.407030E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.561500E-03 |
| Normal-vs-N1 |
4.837200E-03 |
| Normal-vs-N2 |
5.051600E-01 |
| N0-vs-N1 |
6.114400E-01 |
| N0-vs-N2 |
5.145800E-01 |
| N1-vs-N2 |
3.360400E-01 |
|
|
